Memantine and catatonic schizophrenia [3]

American Journal of Psychiatry

Volumn 162, Issue 3, 2005, Pages 626-

  Thomas, Christopher ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CLOZAPINE; HALOPERIDOL; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; BUSH FRANCIS CATATONIA RATING SCALE; CASE REPORT; CATATONIA; CATATONIC SCHIZOPHRENIA; DRUG EFFICACY; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; MALE; MEMANTINE; MIDDLE AGED; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA, CATATONIC; TREATMENT OUTCOME;

EID: 14844312109     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.3.626     Document Type: Letter

References (4)

1. Goff DC, Coyle JT: The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 2001; 158:1367-1377
2. Bush G, Fink M, Petrides, Dowling F, Francis A: Catalonia, I: rating scale and standardized examination. Acta Psychiatr Scand 1996; 93:129-136
3. Northoff G: What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis. Behav Brain Sci 2002; 25:555-604
4. Northoff G, Lins H, Boker H, Danos P, Bogerts B: Therapeutic efficacy of N-methyl D-aspartate antagonist amantadine in febrile catatonia. J Clin Psychopharmacol 1999; 19:484-486